Literature DB >> 24706751

Flavone-resistant Leishmania donovani overexpresses LdMRP2 transporter in the parasite and activates host MRP2 on macrophages to circumvent the flavone-mediated cell death.

Sayan Chowdhury1, Rupkatha Mukhopadhyay2, Sourav Saha1, Amartya Mishra1, Souvik Sengupta3, Syamal Roy2, Hemanta K Majumder4.   

Abstract

In parasites, ATP-binding cassette (ABC) transporters represent an important family of proteins related to drug resistance and other biological activities. Resistance of leishmanial parasites to therapeutic drugs continues to escalate in developing countries, and in many instances, it is due to overexpressed ABC efflux pumps. Progressively adapted baicalein (BLN)-resistant parasites (pB(25)R) show overexpression of a novel ABC transporter, which was classified as ABCC2 or Leishmania donovani multidrug resistance protein 2 (LdMRP2). The protein is primarily localized in the flagellar pocket region and in internal vesicles. Overexpressed LdABCC2 confers substantial BLN resistance to the parasites by rapid drug efflux. The BLN-resistant promastigotes when transformed into amastigotes in macrophage cells cannot be cured by treatment of macrophages with BLN. Amastigote resistance is concomitant with the overexpression of macrophage MRP2 transporter. Reporter analysis and site-directed mutagenesis assays demonstrated that antioxidant response element 1 is activated upon infection. The expression of this phase II detoxifying gene is regulated by NFE2-related factor 2 (Nrf2)-mediated antioxidant response element activation. In view of the fact that the signaling pathway of phosphoinositol 3-kinase controls microfilament rearrangement and translocation of actin-associated proteins, the current study correlates with the intricate pathway of phosphoinositol 3-kinase-mediated nuclear translocation of Nrf2, which activates MRP2 expression in macrophages upon infection by the parasites. In contrast, phalloidin, an agent that prevents depolymerization of actin filaments, inhibits Nrf2 translocation and Mrp2 gene activation by pB(25)R infection. Taken together, these results provide insight into the mechanisms by which resistant clinical isolates of L. donovani induce intracellular events relevant to drug resistance.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Drug Resistance; Flavonoids; Infectious Diseases; Leishmania; Multidrug Transporters

Mesh:

Substances:

Year:  2014        PMID: 24706751      PMCID: PMC4047385          DOI: 10.1074/jbc.M113.539742

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival.

Authors:  Sara B Cullinan; Donna Zhang; Mark Hannink; Edward Arvisais; Randal J Kaufman; J Alan Diehl
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

2.  Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol.

Authors:  Daniel Martin; Ana I Rojo; Marta Salinas; Raquel Diaz; German Gallardo; Jawed Alam; Carlos M Ruiz De Galarreta; Antonio Cuadrado
Journal:  J Biol Chem       Date:  2003-12-19       Impact factor: 5.157

3.  Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts.

Authors:  Asako Hayashi; Hiroshi Suzuki; Ken Itoh; Masayuki Yamamoto; Yuichi Sugiyama
Journal:  Biochem Biophys Res Commun       Date:  2003-10-24       Impact factor: 3.575

4.  PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress.

Authors:  Sara B Cullinan; J Alan Diehl
Journal:  J Biol Chem       Date:  2004-02-20       Impact factor: 5.157

5.  Localization and activity of multidrug resistance protein 1 in the secretory pathway of Leishmania parasites.

Authors:  Matthew A Dodge; Ross F Waller; Larry M C Chow; Muhammad M Zaman; Leanne M Cotton; Malcolm J McConville; Dyann F Wirth
Journal:  Mol Microbiol       Date:  2004-03       Impact factor: 3.501

6.  Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2).

Authors:  Ken Itoh; Mie Mochizuki; Yukio Ishii; Tetsuro Ishii; Takahiro Shibata; Yoshiyuki Kawamoto; Vincent Kelly; Kiyohisa Sekizawa; Koji Uchida; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

7.  Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug.

Authors:  F Javier Pérez-Victoria; Santiago Castanys; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

8.  Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress.

Authors:  Keon Wook Kang; Seung Jin Lee; Jeong Weon Park; Sang Geon Kim
Journal:  Mol Pharmacol       Date:  2002-11       Impact factor: 4.436

9.  Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription.

Authors:  H-C Huang; Truyen Nguyen; Cecil B Pickett
Journal:  J Biol Chem       Date:  2002-08-26       Impact factor: 5.157

10.  Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).

Authors:  Karin Seifert; Sangeeta Matu; F Javier Pérez-Victoria; Santiago Castanys; Francisco Gamarro; Simon L Croft
Journal:  Int J Antimicrob Agents       Date:  2003-10       Impact factor: 5.283

View more
  4 in total

1.  The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India.

Authors:  Neeloo Singh; Mitali Chatterjee; Shyam Sundar
Journal:  Parasit Vectors       Date:  2014-12-17       Impact factor: 3.876

Review 2.  The Potential Role of Nrf2 Signaling in Leishmania Infection Outcomes.

Authors:  Aislan de Carvalho Vivarini; Ulisses Gazos Lopes
Journal:  Front Cell Infect Microbiol       Date:  2020-01-10       Impact factor: 5.293

3.  Antileishmanial Aminopyrazoles: Studies into Mechanisms and Stability of Experimental Drug Resistance.

Authors:  M Van den Kerkhof; D Mabille; S Hendrickx; P Leprohon; C E Mowbray; S Braillard; M Ouellette; L Maes; G Caljon
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

4.  The antioxidant response favors Leishmania parasites survival, limits inflammation and reprograms the host cell metabolism.

Authors:  Marta Reverte; Remzi Onur Eren; Baijayanti Jha; Chantal Desponds; Tiia Snäkä; Florence Prevel; Nathalie Isorce; Lon-Fye Lye; Katherine L Owens; Ulisses Gazos Lopes; Stephen M Beverley; Nicolas Fasel
Journal:  PLoS Pathog       Date:  2021-03-25       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.